MOLECULES BINDING PD-L1 AND USES THEREOF - BEIJING MABWORKS BIOTECH CO LTD

Title:

MOLECULES BINDING PD-L1 AND USES THEREOF

Document Type and Number:

WIPO Patent Application WO/2023/232023

Kind Code:

A1

Abstract:

Disclosed is a molecule, e.g., a single-domain antibody, or a heavy chain only antibody, that specifically binds human PD-L1, and its use in treating diseases such as tumors.

Inventors:

ZHOU XUECHEN (CN)
LIN GUANGZHONG (CN)
LI JIANGMEI (CN)
HU WENQI (CN)
LI FENG (CN)

Application Number:

PCT/CN2023/097090

Publication Date:

December 07, 2023

Filing Date:

May 30, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

BEIJING MABWORKS BIOTECH CO LTD (CN)

International Classes:

C07K16/28; A61K39/395; A61P35/00; C12N15/13

Domestic Patent References:

WO2020001526A1

2020-01-02

Attorney, Agent or Firm:

CHENG & PENG INTELLECTUAL PROPERTY LAW OFFICE (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: RECOMBINANT FUSION PROTEIN TARGETING PD-L1 AND VEGF, AND PREPARATION AND USE THEREOF

Next Patent: SYSTEM AND METHODS FOR DUPLICATING TARGET FRAGMENTS